Literature DB >> 9262979

The breath test--a call for more regional use.

A Heaney1, R M Kalin, J S Collins, R G Watson, R J McFarland.   

Abstract

OBJECTIVE: Although the 13C-urea breath test is commonly used for detection of Helicobacter pylori infection and eradication, access to commercial testing centres for analysis may at times limit its use. We have addressed this issue by establishing a regional-based means of analysis as a Hospital-University collaboration. DESIGN/
METHODS: A blind comparison was undertaken of 13C-urea breath test results performed 'in house' by the stable isotope laboratory in Queen's University Belfast and a commercially available 13C-urea breath test.
RESULTS: The H. pylori status of the patients (n = 110) agreed for all patients (kappa score = 1). The excess values showed good agreement. The cost of the 'in house' breath test was less than 20 pounds compared with 32.90 pounds for the commercial breath test.
CONCLUSION: Regional access to the 13C-urea breath test could decrease costs, increase availability of testing, improve local health services and economy and increase collaborative research opportunities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9262979     DOI: 10.1097/00042737-199707000-00009

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  Non-invasive testing for Helicobacter pylori.

Authors:  M A Stone
Journal:  Postgrad Med J       Date:  1999-02       Impact factor: 2.401

2.  General practitioners' habits and knowledge in relation to the management of H. pylori-associated dyspepsia and their views about a locally available 13-carbon urea breath test.

Authors:  A Heaney; J S Collins; P R Watson; R M Kalin
Journal:  Br J Gen Pract       Date:  2000-03       Impact factor: 5.386

Review 3.  Helicobacter pylori detection and antimicrobial susceptibility testing.

Authors:  Francis Mégraud; Philippe Lehours
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.